Customised bioassay development, pharmacological profiling and compound screening
Aurelia Bioscience is a pre-clinical contract research organisation (CRO) specialising in bioassay development, pharmacological profiling and compound screening.
We work in early stages of the drug discovery pipeline including target identification and validation, hit identification, hit to lead as well as lead identification and optimisation. We have significant experience of different target classes and use cutting edge technologies to deliver client projects in a timely, efficient and cost-effective manner.
Our PhD and pharma trained scientists have decades of experience in pre-clinical discovery, designing and developing low, medium and high throughput assays for hits-to-lead, lead identification and lead optimisation drug discovery phases